Guruswamy et al. reported that the anti-proliferative effect on colon cancer cell line HCT-116 determined by use of celecoxib and lovastatin was due to reduced Caveolin-1 expression in treated cells and the reduced activation of down-stream signaling pathways [37]. Here, CAV1 is linked to colonic neoplasm.